However, mutational inactivation of JAK1, a kinase involved in IFN-I/-II signaling, enables melanoma cells to preserve their immune-evasive HLA-I-low/-negative phenotype in an IFN-rich microenvironment. Here, JAK1 is linked to melanoma.